R2202137 |
Glibenclamide impurity Ⅱ |
Glibenclamide (Glyburide) is an orally active ATP-sensitive K+ channel (KATP) in
|
R2202138 |
FM-479 |
FM-479 is the negative control of FM-381 (HY-102046) and has no activity on JAK3
|
R2202139 |
T56-LIMKi |
T56-LIMKi is a selective inhibitor of LIMK2; inhibits the growth of Panc-1 cells
|
R2202140 |
INE963 |
4-Piperidinol, 4-(aminomethyl)-1-[5-[2-methoxy-6-(1-methylethyl)-3-pyridinyl]imi
|
R2202141 |
JQKD-82 |
JQKD82 (JADA82) is a cell-permeable and selective KDM5 inhibitor. JQKD82 increas
|
R2202142 |
SKF89976A hydrochloride |
SKF89976A hydrochloride is a selective GABA transporter (GAT-1) inhibitor with I
|
R2202143 |
Complement factor D-IN-2 |
Complement factor D-IN-2 is an inhibitor of complement factor D extracted from p
|
R2202144 |
SR1664 |
SR1664 is a PPARγ antagonist. SR1664 binds to PPARγ and potently inhibits Cdk5-m
|
R2202145 |
Bocidelpar |
Bocidelpar is a modulator of peroxisome proliferator-activated receptor del
|
R2202146 |
ML339 |
ML339 is a potent and selective CXCR6 (IC50 of 140 nM) antagonist that is select
|
R2202147 |
SCD1 inhibitor-3 |
SCD1 inhibitor-3 is a safe, potent and orally active SCD1 inhibitor. SCD1 inhibi
|
R2202148 |
YTX-465 |
YTX-465 is a stearoyl-CoA desaturase (Ole1/SCD) inhibitor. YTX-465 inhibits Ole1
|
R2202149 |
BMS-615 |
TLR7/8/9-IN-1 is a potent and orally bioavailable small molecule antagonist (IC5
|
R2202150 |
VU6015929 |
VU6015929 is a potent, selective and orally active dual discoidin domain re
|
R2202151 |
Tavapadon |
Tavapadon (PF-06649751) is an orally active and highly selective dopamine D1/D5
|
R2202152 |
suvn-911 |
SUVN-911 is a potent, selective, brain penetrated and orally bioavailable neuron
|
R2202153 |
MDR652 |
MDR-652 is a highly specific and efficacious transient receptor potential vanill
|
R2202154 |
DS-1971a |
DS-1971a is a potent, selective, and orally active NaV1.7 inhibitor, with IC50s
|
R2202155 |
PK68 |
PK68 is a potent and selective type II inhibitor of receptor-interacting kinase
|
R2202156 |
Seltorexant |
Seltorexant (JNJ-42847922) is an orally active, high-affinity, and selective ore
|
R2202157 |
Rineterkib;ERK-IN-1 |
Rineterkib (compound B) is an orally active RAF and ERK1/2 inhibitor in the stud
|
R2202158 |
Licogliflozin |
Licogliflozin is a sodium glucose cotransporter (SGLT1 and SGLT2) inhibitor.
|
R2202159 |
LOX-IN-3 dihydrochloride |
LOX-IN-3 dihydrochloride is an orally active lysyl oxidase (LOX) inhibitor. LOX-
|
R2202160 |
ACH-000143 |
ACH-000143 is a potent and orally active melatonin receptor agonist, with EC50 v
|
R2202161 |
Nifeviroc |
Nifeviroc is an orally active CCR5 antagonist. Nifeviroc is used for the study o
|